Earnings Call · Q4 FY2025·2026-04-16

Q4 25EPS -2.67%·Rev n/aQ3 25EPS +96.29%·Rev n/aQ2 25EPS +98.17%·Rev n/aQ1 25EPS +100.00%*·Rev n/a⚠ consensus missing

Traws Pharma, Inc. TRAW

John Fraunces — IR Representative

Iain Dukes — Chief Executive Officer

Charles Parker — CFO

−22.6%1d on move date−23.4% vs SPY3d−21.4%5d−19.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRAW calls or request research access.

More TRAW calls Browse calls Request research access